Jorge A. Marrero, MD, MS - Surveying the View From the Driver ’s Seat in Hepatocellular Carcinoma: Bringing Into Focus Hepatology’s Key Role in Guiding HCC Care Down the Path to Improved Outcomes
Surveying the View From the Driver’s Seat in Hepatocellular Carcinoma: Bringing Into Focus Hepatology’s Key Role in Guiding HCC Care Down the Path to Improved Outcomes (Source: Peerview CME/CE Video Podcast - Internal Medicine International)
Source: Peerview CME/CE Video Podcast - Internal Medicine International - January 12, 2019 Category: Internal Medicine Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: video

Jorge A. Marrero, MD, MS - Surveying the View From the Driver ’s Seat in Hepatocellular Carcinoma: Bringing Into Focus Hepatology’s Key Role in Guiding HCC Care Down the Path to Improved Outcomes
Surveying the View From the Driver’s Seat in Hepatocellular Carcinoma: Bringing Into Focus Hepatology’s Key Role in Guiding HCC Care Down the Path to Improved Outcomes (Source: PeerView CME/CE Video Podcast - Oncology)
Source: PeerView CME/CE Video Podcast - Oncology - January 12, 2019 Category: Cancer & Oncology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: video

Riccardo Lencioni, MD, FSIR, EBIR - At the Intersection of Local and Systemic Therapy in the Management of Hepatocellular Carcinoma: Preparing for the Next Evolution in Multimodal Treatment
At the Intersection of Local and Systemic Therapy in the Management of Hepatocellular Carcinoma: Preparing for the Next Evolution in Multimodal Treatment (Source: PeerView CME/CE Video Podcast - Oncology)
Source: PeerView CME/CE Video Podcast - Oncology - May 29, 2018 Category: Cancer & Oncology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: video

Ghassan Abou-Alfa, MD, MBA - New Options, Emerging Combinations in Advanced Hepatocellular Carcinoma: Are Management Approaches Poised For Transformation?
New Options, Emerging Combinations in Advanced Hepatocellular Carcinoma: Are Management Approaches Poised For Transformation? (Source: PeerView CME/CE Video Podcast - Oncology)
Source: PeerView CME/CE Video Podcast - Oncology - April 14, 2018 Category: Cancer & Oncology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: video

Oncogene Addiction
NCI Center for Cancer Research Eminent Lecture Dr. Felsher obtained a B.A. in Chemistry at the University of Chicago, a M.D. Ph.D. from the University of California, Los Angeles School of Medicine. He performed his graduate work in Molecular Biology/Immunology under Dr. Jonathan Braun. He trained in Internal Medicine at the Hospital of the University of Pennsylvania and Oncology at the University of California, San Francisco and his post-doctoral research under Dr. J. Michael Bishop. Dr. Felsher has been faculty at Stanford University for 16 years and performing both basic and translational cancer research and is the foun...
Source: Videocast - All Events - May 18, 2016 Category: Journals (General) Tags: Upcoming Events Source Type: video

CC Grand Rounds: (1) Combined Antiangiogenic Agents for Hepatocellular Carcinoma and (2) Immune Based Therapies for Gastrointestinal Malignancies
Presented by: (1) Austin Duffy, MD Staff Clinician, Gastrointestinal Malignancy Section, Thoracic and Gastrointestinal Oncology Branch, NCI, NIH and (2) Tim F. Greten, MD Senior Investigator and Chief, Gastrointestinal Malignancy Section, Thoracic and GastrointestCategory: Clinical Center Grand RoundsAired date: 03/23/2016 (Source: Videocast - All Events)
Source: Videocast - All Events - March 24, 2016 Category: Journals (General) Tags: Past Events Source Type: video

Dissecting KRAS-driven Pancreatic Tumorigenesis
CCR Eminent Lectures Dr. Brian Lewis is an Associate Professor in the Department of Molecular, Cell and Cancer Biology at the University of Massachusetts Medical School (UMMS). He is also the Associate Dean for Student Diversity in the Graduate School of Biomedical Sciences at UMMS. Dr. Lewis received his BS in Biology from the University of California, Los Angeles and his PhD, also in Biology, from the Johns Hopkins University. After completing postdoctoral training at the National Institutes of Health and Memorial Sloan-Kettering Cancer Center, Lewis joined the faculty at UMMS as an Assistant Prof...
Source: Videocast - All Events - March 17, 2016 Category: Journals (General) Tags: Upcoming Events Source Type: video

CC Grand Rounds: (1) Combined Antiangiogenic Agents for Hepatocellular Carcinoma and (2) Immune Based Therapies for Gastrointestinal Malignancies
For more information go to http://www.cc.nih.gov/about/news/grcurrent.htmlAir date: 3/23/2016 12:00:00 PM (Source: Videocast - All Events)
Source: Videocast - All Events - February 19, 2016 Category: Journals (General) Tags: Upcoming Events Source Type: video

Immunology and Immunotherapy of Hepatocellular Carcinoma
Presented by: Tim F. Greten, M.D., Head, Gastrointestinal Malignancy Section, Thoracic and Gastrointestinal Oncology Branch, Center for Cancer Research, NCI, NIH Category: NCI CCR Grand Rounds (HHS Only)Aired date: 11/20/2015 (Source: Videocast - All Events)
Source: Videocast - All Events - November 24, 2015 Category: Journals (General) Tags: Past Events Source Type: video

Immunology and Immunotherapy of Hepatocellular Carcinoma
NCI’s Center for Cancer Research (CCR) Grand Rounds Dr. Greten received his medical training at ChristianAlbrechts University in Kiel, Germany. He did an internship in Munich followedby a postdoctoral fellowship at The Johns Hopkins University, Baltimore,Maryland, in the laboratory of Drew Pardoll and Liz Jaffee, where he initiatedhis work in the field of tumor immunology. In 1999 Dr. Greten finished histraining in internal medicine, medical oncology, and gastroenterology atHannover Medical School. He then served as an associate professor in theDepartment of Gastroenterology, Hepatology, and Endocrinology. In Februar...
Source: Videocast - All Events - November 16, 2015 Category: Journals (General) Tags: Upcoming Events Source Type: video

Normalizing the Tumor Microenvironment to Enhance Cancer Treatment
Wednesday Afternoon Lecture Series For more than three decades, Dr. Jain's laboratory research has focused on one challenge: improving the delivery and efficacy of anti-cancer therapies. Working on the hypothesis that the abnormal tumor microenvironment fuels tumor progression and treatment resistance, the Jain laboratory has developed an array of novel imaging technologies and animal models as well as mathematical models to unravel the complex biology of tumors. They demonstrated that the blood and lymphatic vasculature, fibroblasts, immune cells, and the extracellular matrix associated with tumors are abnormal and togeth...
Source: Videocast - All Events - October 21, 2014 Category: Journals (General) Tags: Upcoming Events Source Type: video

Andrew X. Zhu, MD, PhD - Expert Perspectives on the Promises and Limitations of Expanded Use of Systemic Therapies Throughout the Hepatocellular Carcinoma Disease Continuum
(Source: Peerview CME/CE Video Podcast - Internal Medicine International)
Source: Peerview CME/CE Video Podcast - Internal Medicine International - November 14, 2013 Category: Internal Medicine Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: video